Skip to content

A SINGLE BLIND, SINGLE DOSE STUDY OF THE SEDATIVE EFFECTS OF THIOCOLCHICOSIDE, TIZANIDINE AND CYCLOBENZAPRINE IN HEALTHY MALE, HUMAN VOLUNTEERS - TCC-C-001

A SINGLE BLIND, SINGLE DOSE STUDY OF THE SEDATIVE EFFECTS OF THIOCOLCHICOSIDE, TIZANIDINE AND CYCLOBENZAPRINE IN HEALTHY MALE, HUMAN VOLUNTEERS - TCC-C-001

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-004665-25-IT
Enrollment
Unknown
Registered
2008-11-07
Start date
2008-09-04
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

muscle spasm MedDRA version: 9.1 Level: HLGT Classification code 10028393 Term: Musculoskeletal and connective tissue disorders NEC

Interventions

Trade Name: TIOSIDE*20CPS RIG 4MG Pharmaceutical Form: Capsule, hard INN or Proposed INN: Thiocolchicoside Concentration unit: IU/mg international unit(s)/milligram Concentration type: equal Concentra

Sponsors

MUTUAL PHARMACEUTICAL COMPANY
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: HEALTHY MALE VOLUNTEERS,18-40 YEARS, NORMAL HISTORY AND PHYSICAL EXAMINATION NORMAL LAB TESTS LESS THAN 18 UNITS ALCOHOL/WEEK WRITTEN INFORMED CONSENT Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: CURRENT ADMINISTRATION OF ANY MEDICATION ON A CHRONIC BASIS, CLINICALLY SIGNIFICANT CONCOMITANT SDIEASES, MORE THAN 10 SIGARETTE/DAY, INVESTIGAT.COMP,6 MONTH PRIOR TO STUDY, LACK OF INFORMED CONSENSE

Design outcomes

Primary

MeasureTime frame
Main Objective: EXTENT OF SEDATION INDUCED BY THE THREE STUDY DRUGS IN COMPARISON WITH PLACEBO;Secondary Objective: NONE;Primary end point(s): EXTENT OF SEDATION INDUCED BY THE THREE STUDY DRUGS IN COMPARISON WITH PLACEBO

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026